Can China Sustain a Surge in Oncology Drug Innovation?

Measures announced to encourage development of innovative drugs

China's healthcare security authority on Tuesday announced a series of measures to encourage novel drug development, including the creation of a commercial insurance catalog for innovative medicines that patients could be reimbursed for.

Can China sustain a surge in oncology drug innovation?

The country’s trajectory may get a boost from anticipated results of a Keytruda rival’s U.S. trials.

Challenges and opportunities in oncology drug development and clinical research in China

As one of the world’s most populous countries, China bears a heavy burden and a broad spectrum of cancers, including unique types, providing a unique …

China’s rise splits US biotech investors: Cash in, or counter?

China’s ascent in drug development has kicked off debate among American investors over how to respond. Chinese companies are now competitive in some of the hottest areas of drug research, including obesity and cancer. As ...

China Unveils New Policy to Boost Innovative Drug Development and Market Access

China announces sweeping new measures to fast-track innovative drug R&D, streamline market access, and expand insurance coverage in 2025.